These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 22230389)
41. Interleukin-10 protects against atherosclerosis by modulating multiple atherogenic macrophage function. Han X; Boisvert WA Thromb Haemost; 2015 Mar; 113(3):505-12. PubMed ID: 25373619 [TBL] [Abstract][Full Text] [Related]
42. Differential role of monocyte subsets in atherosclerosis. Hristov M; Weber C Thromb Haemost; 2011 Nov; 106(5):757-62. PubMed ID: 21901241 [TBL] [Abstract][Full Text] [Related]
47. 6-mercaptopurine inhibits atherosclerosis in apolipoprotein e*3-leiden transgenic mice through atheroprotective actions on monocytes and macrophages. Pols TW; Bonta PI; Pires NM; Otermin I; Vos M; de Vries MR; van Eijk M; Roelofsen J; Havekes LM; Quax PH; van Kuilenburg AB; de Waard V; Pannekoek H; de Vries CJ Arterioscler Thromb Vasc Biol; 2010 Aug; 30(8):1591-7. PubMed ID: 20413732 [TBL] [Abstract][Full Text] [Related]
48. CD137 (4-1BB) deficiency reduces atherosclerosis in hyperlipidemic mice. Jeon HJ; Choi JH; Jung IH; Park JG; Lee MR; Lee MN; Kim B; Yoo JY; Jeong SJ; Kim DY; Park JE; Park HY; Kwack K; Choi BK; Kwon BS; Oh GT Circulation; 2010 Mar; 121(9):1124-33. PubMed ID: 20176988 [TBL] [Abstract][Full Text] [Related]
49. Immune-Inflammation in Atherosclerosis: A New Twist in an Old Tale. Talepoor AG; Fouladseresht H; Khosropanah S; Doroudchi M Endocr Metab Immune Disord Drug Targets; 2020; 20(4):525-545. PubMed ID: 31622224 [TBL] [Abstract][Full Text] [Related]
50. Serum amyloid A induction of cytokines in monocytes/macrophages and lymphocytes. Song C; Hsu K; Yamen E; Yan W; Fock J; Witting PK; Geczy CL; Freedman SB Atherosclerosis; 2009 Dec; 207(2):374-83. PubMed ID: 19535079 [TBL] [Abstract][Full Text] [Related]
51. Towards a role of interleukin-32 in atherosclerosis. Heinhuis B; Popa CD; van Tits BL; Kim SH; Zeeuwen PL; van den Berg WB; van der Meer JW; van der Vliet JA; Stalenhoef AF; Dinarello CA; Netea MG; Joosten LA Cytokine; 2013 Oct; 64(1):433-40. PubMed ID: 23727326 [TBL] [Abstract][Full Text] [Related]
52. Immune and inflammatory mechanisms of atherosclerosis (*). Galkina E; Ley K Annu Rev Immunol; 2009; 27():165-97. PubMed ID: 19302038 [TBL] [Abstract][Full Text] [Related]
56. Adventitial lymphatic vessels -- an important role in atherosclerosis. Xu X; Lin H; Lv H; Zhang M; Zhang Y Med Hypotheses; 2007; 69(6):1238-41. PubMed ID: 17825501 [TBL] [Abstract][Full Text] [Related]
57. The Dual Role of Surfactant Protein-D in Vascular Inflammation and Development of Cardiovascular Disease. Colmorten KB; Nexoe AB; Sorensen GL Front Immunol; 2019; 10():2264. PubMed ID: 31616435 [TBL] [Abstract][Full Text] [Related]
58. Contribution of neovascularization and intraplaque haemorrhage to atherosclerotic plaque progression and instability. Chistiakov DA; Orekhov AN; Bobryshev YV Acta Physiol (Oxf); 2015 Mar; 213(3):539-53. PubMed ID: 25515699 [TBL] [Abstract][Full Text] [Related]
59. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte/Macrophage Differentiation in ApoE-/- Mice. Nakashiro S; Matoba T; Umezu R; Koga J; Tokutome M; Katsuki S; Nakano K; Sunagawa K; Egashira K Arterioscler Thromb Vasc Biol; 2016 Mar; 36(3):491-500. PubMed ID: 26821947 [TBL] [Abstract][Full Text] [Related]